Intelligent drugs based on notch protein remodeling: a defensive targeting strategy for tumor therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Drug Delivery Systems

Background:

• Systemic drug administration in cancer therapy faces biological barriers, causing drug retention in healthy tissues and adverse side effects.
• Precise drug deployment at tumor sites is crucial for improving treatment efficacy and reducing toxicity.
• Current targeting strategies often focus on increasing drug concentration, potentially leading to off-target effects.

Purpose of the Study:

• To develop an intelligent drug delivery system that selectively releases therapeutic agents at tumor sites.
• To engineer mesenchymal stem cells (MSCs) with an "intelligent response program" for autonomous tumor cell recognition and drug deployment.
• To investigate a "defensive" drug delivery strategy that prevents drug presence in healthy tissues.

Main Methods:

• Engineered mesenchymal stem cells (MSCs) with an intelligent response program (iMSC^Endostatin) were developed.
• The iMSC^Endostatin system was designed to autonomously perceive and differentiate between tumor and non-tumor cells.
• A logical connection was established between tumor-specific signals and controlled drug release, using endostatin for Her2 (+) tumors as a model.

Main Results:

• The intelligent drug system demonstrated the ability to selectively deploy drugs specifically at the tumor site.
• This targeted delivery mechanism effectively localized drug toxicity to the tumor, minimizing exposure to healthy tissues.
• The iMSC^Endostatin system functions as a "defensive" strategy, contrasting with traditional "aggressive" targeting methods.

Conclusions:

• Intelligent drug systems, exemplified by iMSC^Endostatin, offer a novel approach to cancer therapy by enabling precise, site-specific drug release.
• This technology holds promise for significantly reducing the side effects associated with conventional systemic chemotherapy.
• The "wisdom" endowed in MSCs allows for autonomous recognition and targeted drug delivery, paving the way for safer and more effective cancer treatments.